English
简体中文
Total: £ 56.28
Published Date: 2025-01-13 | Pages: 82 | Tables: 79 | Pharma & Healthcare
The global market for Drugs for Schistosomiasis was valued at US$ 88.3 million in the year 2024 and is projected to reach a revised size of US$ 114 million by 2031, growing at a CAGR of 3.8% during the forecast period.
Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty.
Shin Poong, Merck, Bayer, EIPICO, Chandra Bhagat Pharma and Taj Pharmaceuticals are the main manufacturers of drugs for Schistosomiasis.
East Africa is the largest region of drugs for Schistosomiasis, whose market share is about 24%,
Followed by West Africa(20%).
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drugs for Schistosomiasis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Schistosomiasis.
The Drugs for Schistosomiasis market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drugs for Schistosomiasis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drugs for Schistosomiasis manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Shin Poong
Merck
Bayer
EIPICO
Chandra Bhagat Pharma
Taj Pharmaceuticals
Segment by Type
Praziquantel
Oxamniquine
Other
Segment by Application
S. haematobium
S. mansoni
S. japonicum
S. mekongi
S. intercalatum
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drugs for Schistosomiasis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drugs for Schistosomiasis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Drugs for Schistosomiasis Market Overview
1.1 Product Definition
1.2 Drugs for Schistosomiasis by Type
1.2.1 Global Drugs for Schistosomiasis Market Value Comparison by Type (2024 VS 2031)
1.2.2 Praziquantel
1.2.3 Oxamniquine
1.2.4 Other
1.3 Drugs for Schistosomiasis by Application
1.3.1 Global Drugs for Schistosomiasis Market Value by Application (2024 VS 2031)
1.3.2 S. haematobium
1.3.3 S. mansoni
1.3.4 S. japonicum
1.3.5 S. mekongi
1.3.6 S. intercalatum
1.4 Global Drugs for Schistosomiasis Market Size Estimates and Forecasts
1.4.1 Global Drugs for Schistosomiasis Revenue 2020-2031
1.4.2 Global Drugs for Schistosomiasis Sales 2020-2031
1.4.3 Global Drugs for Schistosomiasis Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Drugs for Schistosomiasis Market Competition by Manufacturers
2.1 Global Drugs for Schistosomiasis Sales Market Share by Manufacturers (2020-2025)
2.2 Global Drugs for Schistosomiasis Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Drugs for Schistosomiasis Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Drugs for Schistosomiasis, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Drugs for Schistosomiasis, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drugs for Schistosomiasis, Product Type & Application
2.7 Global Key Manufacturers of Drugs for Schistosomiasis, Date of Enter into This Industry
2.8 Global Drugs for Schistosomiasis Market Competitive Situation and Trends
2.8.1 Global Drugs for Schistosomiasis Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Drugs for Schistosomiasis Players Market Share by Revenue
2.8.3 Global Drugs for Schistosomiasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Drugs for Schistosomiasis Market Scenario by Region
3.1 Global Drugs for Schistosomiasis Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Drugs for Schistosomiasis Sales by Region: 2020-2031
3.2.1 Global Drugs for Schistosomiasis Sales by Region: 2020-2025
3.2.2 Global Drugs for Schistosomiasis Sales by Region: 2026-2031
3.3 Global Drugs for Schistosomiasis Revenue by Region: 2020-2031
3.3.1 Global Drugs for Schistosomiasis Revenue by Region: 2020-2025
3.3.2 Global Drugs for Schistosomiasis Revenue by Region: 2026-2031
3.4 North America Drugs for Schistosomiasis Market Facts & Figures by Country
3.4.1 North America Drugs for Schistosomiasis Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Drugs for Schistosomiasis Sales by Country (2020-2031)
3.4.3 North America Drugs for Schistosomiasis Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Drugs for Schistosomiasis Market Facts & Figures by Country
3.5.1 Europe Drugs for Schistosomiasis Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Drugs for Schistosomiasis Sales by Country (2020-2031)
3.5.3 Europe Drugs for Schistosomiasis Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drugs for Schistosomiasis Market Facts & Figures by Region
3.6.1 Asia Pacific Drugs for Schistosomiasis Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Drugs for Schistosomiasis Sales by Region (2020-2031)
3.6.3 Asia Pacific Drugs for Schistosomiasis Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Drugs for Schistosomiasis Market Facts & Figures by Country
3.7.1 Latin America Drugs for Schistosomiasis Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Drugs for Schistosomiasis Sales by Country (2020-2031)
3.7.3 Latin America Drugs for Schistosomiasis Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Drugs for Schistosomiasis Market Facts & Figures by Country
3.8.1 Middle East and Africa Drugs for Schistosomiasis Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Drugs for Schistosomiasis Sales by Country (2020-2031)
3.8.3 Middle East and Africa Drugs for Schistosomiasis Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Drugs for Schistosomiasis Sales by Type (2020-2031)
4.1.1 Global Drugs for Schistosomiasis Sales by Type (2020-2025)
4.1.2 Global Drugs for Schistosomiasis Sales by Type (2026-2031)
4.1.3 Global Drugs for Schistosomiasis Sales Market Share by Type (2020-2031)
4.2 Global Drugs for Schistosomiasis Revenue by Type (2020-2031)
4.2.1 Global Drugs for Schistosomiasis Revenue by Type (2020-2025)
4.2.2 Global Drugs for Schistosomiasis Revenue by Type (2026-2031)
4.2.3 Global Drugs for Schistosomiasis Revenue Market Share by Type (2020-2031)
4.3 Global Drugs for Schistosomiasis Price by Type (2020-2031)
5 Segment by Application
5.1 Global Drugs for Schistosomiasis Sales by Application (2020-2031)
5.1.1 Global Drugs for Schistosomiasis Sales by Application (2020-2025)
5.1.2 Global Drugs for Schistosomiasis Sales by Application (2026-2031)
5.1.3 Global Drugs for Schistosomiasis Sales Market Share by Application (2020-2031)
5.2 Global Drugs for Schistosomiasis Revenue by Application (2020-2031)
5.2.1 Global Drugs for Schistosomiasis Revenue by Application (2020-2025)
5.2.2 Global Drugs for Schistosomiasis Revenue by Application (2026-2031)
5.2.3 Global Drugs for Schistosomiasis Revenue Market Share by Application (2020-2031)
5.3 Global Drugs for Schistosomiasis Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Shin Poong
6.1.1 Shin Poong Company Information
6.1.2 Shin Poong Description and Business Overview
6.1.3 Shin Poong Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Shin Poong Drugs for Schistosomiasis Product Portfolio
6.1.5 Shin Poong Recent Developments/Updates
6.2 Merck
6.2.1 Merck Company Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck Drugs for Schistosomiasis Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Company Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bayer Drugs for Schistosomiasis Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 EIPICO
6.4.1 EIPICO Company Information
6.4.2 EIPICO Description and Business Overview
6.4.3 EIPICO Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2020-2025)
6.4.4 EIPICO Drugs for Schistosomiasis Product Portfolio
6.4.5 EIPICO Recent Developments/Updates
6.5 Chandra Bhagat Pharma
6.5.1 Chandra Bhagat Pharma Company Information
6.5.2 Chandra Bhagat Pharma Description and Business Overview
6.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Chandra Bhagat Pharma Drugs for Schistosomiasis Product Portfolio
6.5.5 Chandra Bhagat Pharma Recent Developments/Updates
6.6 Taj Pharmaceuticals
6.6.1 Taj Pharmaceuticals Company Information
6.6.2 Taj Pharmaceuticals Description and Business Overview
6.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Taj Pharmaceuticals Drugs for Schistosomiasis Product Portfolio
6.6.5 Taj Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drugs for Schistosomiasis Industry Chain Analysis
7.2 Drugs for Schistosomiasis Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drugs for Schistosomiasis Production Mode & Process Analysis
7.4 Drugs for Schistosomiasis Sales and Marketing
7.4.1 Drugs for Schistosomiasis Sales Channels
7.4.2 Drugs for Schistosomiasis Distributors
7.5 Drugs for Schistosomiasis Customer Analysis
8 Drugs for Schistosomiasis Market Dynamics
8.1 Drugs for Schistosomiasis Industry Trends
8.2 Drugs for Schistosomiasis Market Drivers
8.3 Drugs for Schistosomiasis Market Challenges
8.4 Drugs for Schistosomiasis Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Drugs for Schistosomiasis Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Drugs for Schistosomiasis Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Drugs for Schistosomiasis Market Competitive Situation by Manufacturers in 2024
Table 4. Global Drugs for Schistosomiasis Sales (M Units) of Key Manufacturers (2020-2025)
Table 5. Global Drugs for Schistosomiasis Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Drugs for Schistosomiasis Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Drugs for Schistosomiasis Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Drugs for Schistosomiasis Average Price (USD/K Units) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Drugs for Schistosomiasis, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Drugs for Schistosomiasis, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Drugs for Schistosomiasis, Product Type & Application
Table 12. Global Key Manufacturers of Drugs for Schistosomiasis, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Drugs for Schistosomiasis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Schistosomiasis as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Drugs for Schistosomiasis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Drugs for Schistosomiasis Sales by Region (2020-2025) & (M Units)
Table 18. Global Drugs for Schistosomiasis Sales Market Share by Region (2020-2025)
Table 19. Global Drugs for Schistosomiasis Sales by Region (2026-2031) & (M Units)
Table 20. Global Drugs for Schistosomiasis Sales Market Share by Region (2026-2031)
Table 21. Global Drugs for Schistosomiasis Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Drugs for Schistosomiasis Revenue Market Share by Region (2020-2025)
Table 23. Global Drugs for Schistosomiasis Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Drugs for Schistosomiasis Revenue Market Share by Region (2026-2031)
Table 25. North America Drugs for Schistosomiasis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Drugs for Schistosomiasis Sales by Country (2020-2025) & (M Units)
Table 27. North America Drugs for Schistosomiasis Sales by Country (2026-2031) & (M Units)
Table 28. North America Drugs for Schistosomiasis Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Drugs for Schistosomiasis Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Drugs for Schistosomiasis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Drugs for Schistosomiasis Sales by Country (2020-2025) & (M Units)
Table 32. Europe Drugs for Schistosomiasis Sales by Country (2026-2031) & (M Units)
Table 33. Europe Drugs for Schistosomiasis Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Drugs for Schistosomiasis Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Drugs for Schistosomiasis Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Drugs for Schistosomiasis Sales by Region (2020-2025) & (M Units)
Table 37. Asia Pacific Drugs for Schistosomiasis Sales by Region (2026-2031) & (M Units)
Table 38. Asia Pacific Drugs for Schistosomiasis Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Drugs for Schistosomiasis Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Drugs for Schistosomiasis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Drugs for Schistosomiasis Sales by Country (2020-2025) & (M Units)
Table 42. Latin America Drugs for Schistosomiasis Sales by Country (2026-2031) & (M Units)
Table 43. Latin America Drugs for Schistosomiasis Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Drugs for Schistosomiasis Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Drugs for Schistosomiasis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Drugs for Schistosomiasis Sales by Country (2020-2025) & (M Units)
Table 47. Middle East and Africa Drugs for Schistosomiasis Sales by Country (2026-2031) & (M Units)
Table 48. Middle East and Africa Drugs for Schistosomiasis Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Drugs for Schistosomiasis Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Drugs for Schistosomiasis Sales (M Units) by Type (2020-2025)
Table 51. Global Drugs for Schistosomiasis Sales (M Units) by Type (2026-2031)
Table 52. Global Drugs for Schistosomiasis Sales Market Share by Type (2020-2025)
Table 53. Global Drugs for Schistosomiasis Sales Market Share by Type (2026-2031)
Table 54. Global Drugs for Schistosomiasis Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Drugs for Schistosomiasis Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Drugs for Schistosomiasis Revenue Market Share by Type (2020-2025)
Table 57. Global Drugs for Schistosomiasis Revenue Market Share by Type (2026-2031)
Table 58. Global Drugs for Schistosomiasis Price (USD/K Units) by Type (2020-2025)
Table 59. Global Drugs for Schistosomiasis Price (USD/K Units) by Type (2026-2031)
Table 60. Global Drugs for Schistosomiasis Sales (M Units) by Application (2020-2025)
Table 61. Global Drugs for Schistosomiasis Sales (M Units) by Application (2026-2031)
Table 62. Global Drugs for Schistosomiasis Sales Market Share by Application (2020-2025)
Table 63. Global Drugs for Schistosomiasis Sales Market Share by Application (2026-2031)
Table 64. Global Drugs for Schistosomiasis Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Drugs for Schistosomiasis Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Drugs for Schistosomiasis Revenue Market Share by Application (2020-2025)
Table 67. Global Drugs for Schistosomiasis Revenue Market Share by Application (2026-2031)
Table 68. Global Drugs for Schistosomiasis Price (USD/K Units) by Application (2020-2025)
Table 69. Global Drugs for Schistosomiasis Price (USD/K Units) by Application (2026-2031)
Table 70. Shin Poong Company Information
Table 71. Shin Poong Description and Business Overview
Table 72. Shin Poong Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 73. Shin Poong Drugs for Schistosomiasis Product
Table 74. Shin Poong Recent Developments/Updates
Table 75. Merck Company Information
Table 76. Merck Description and Business Overview
Table 77. Merck Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 78. Merck Drugs for Schistosomiasis Product
Table 79. Merck Recent Developments/Updates
Table 80. Bayer Company Information
Table 81. Bayer Description and Business Overview
Table 82. Bayer Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 83. Bayer Drugs for Schistosomiasis Product
Table 84. Bayer Recent Developments/Updates
Table 85. EIPICO Company Information
Table 86. EIPICO Description and Business Overview
Table 87. EIPICO Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 88. EIPICO Drugs for Schistosomiasis Product
Table 89. EIPICO Recent Developments/Updates
Table 90. Chandra Bhagat Pharma Company Information
Table 91. Chandra Bhagat Pharma Description and Business Overview
Table 92. Chandra Bhagat Pharma Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 93. Chandra Bhagat Pharma Drugs for Schistosomiasis Product
Table 94. Chandra Bhagat Pharma Recent Developments/Updates
Table 95. Taj Pharmaceuticals Company Information
Table 96. Taj Pharmaceuticals Description and Business Overview
Table 97. Taj Pharmaceuticals Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 98. Taj Pharmaceuticals Drugs for Schistosomiasis Product
Table 99. Taj Pharmaceuticals Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Drugs for Schistosomiasis Distributors List
Table 103. Drugs for Schistosomiasis Customers List
Table 104. Drugs for Schistosomiasis Market Trends
Table 105. Drugs for Schistosomiasis Market Drivers
Table 106. Drugs for Schistosomiasis Market Challenges
Table 107. Drugs for Schistosomiasis Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Product Picture of Drugs for Schistosomiasis
Figure 2. Global Drugs for Schistosomiasis Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Drugs for Schistosomiasis Market Share by Type: 2024 & 2031
Figure 4. Praziquantel Product Picture
Figure 5. Oxamniquine Product Picture
Figure 6. Other Product Picture
Figure 7. Global Drugs for Schistosomiasis Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Drugs for Schistosomiasis Market Share by Application: 2024 & 2031
Figure 9. S. haematobium
Figure 10. S. mansoni
Figure 11. S. japonicum
Figure 12. S. mekongi
Figure 13. S. intercalatum
Figure 14. Global Drugs for Schistosomiasis Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Drugs for Schistosomiasis Market Size (2020-2031) & (US$ Million)
Figure 16. Global Drugs for Schistosomiasis Sales (2020-2031) & (M Units)
Figure 17. Global Drugs for Schistosomiasis Average Price (USD/K Units) & (2020-2031)
Figure 18. Drugs for Schistosomiasis Report Years Considered
Figure 19. Drugs for Schistosomiasis Sales Share by Manufacturers in 2024
Figure 20. Global Drugs for Schistosomiasis Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Drugs for Schistosomiasis Players: Market Share by Revenue in Drugs for Schistosomiasis in 2024
Figure 22. Drugs for Schistosomiasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Drugs for Schistosomiasis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Drugs for Schistosomiasis Sales Market Share by Country (2020-2031)
Figure 25. North America Drugs for Schistosomiasis Revenue Market Share by Country (2020-2031)
Figure 26. U.S. Drugs for Schistosomiasis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Drugs for Schistosomiasis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Drugs for Schistosomiasis Sales Market Share by Country (2020-2031)
Figure 29. Europe Drugs for Schistosomiasis Revenue Market Share by Country (2020-2031)
Figure 30. Germany Drugs for Schistosomiasis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Drugs for Schistosomiasis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Drugs for Schistosomiasis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Drugs for Schistosomiasis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Drugs for Schistosomiasis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Drugs for Schistosomiasis Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Drugs for Schistosomiasis Revenue Market Share by Region (2020-2031)
Figure 37. China Drugs for Schistosomiasis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Drugs for Schistosomiasis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Drugs for Schistosomiasis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Drugs for Schistosomiasis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Drugs for Schistosomiasis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan Drugs for Schistosomiasis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Indonesia Drugs for Schistosomiasis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Thailand Drugs for Schistosomiasis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Malaysia Drugs for Schistosomiasis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Philippines Drugs for Schistosomiasis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Latin America Drugs for Schistosomiasis Sales Market Share by Country (2020-2031)
Figure 48. Latin America Drugs for Schistosomiasis Revenue Market Share by Country (2020-2031)
Figure 49. Mexico Drugs for Schistosomiasis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Brazil Drugs for Schistosomiasis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Argentina Drugs for Schistosomiasis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Middle East and Africa Drugs for Schistosomiasis Sales Market Share by Country (2020-2031)
Figure 53. Middle East and Africa Drugs for Schistosomiasis Revenue Market Share by Country (2020-2031)
Figure 54. Turkey Drugs for Schistosomiasis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Saudi Arabia Drugs for Schistosomiasis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. U.A.E Drugs for Schistosomiasis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Global Sales Market Share of Drugs for Schistosomiasis by Type (2020-2031)
Figure 58. Global Revenue Market Share of Drugs for Schistosomiasis by Type (2020-2031)
Figure 59. Global Drugs for Schistosomiasis Price (USD/K Units) by Type (2020-2031)
Figure 60. Global Sales Market Share of Drugs for Schistosomiasis by Application (2020-2031)
Figure 61. Global Revenue Market Share of Drugs for Schistosomiasis by Application (2020-2031)
Figure 62. Global Drugs for Schistosomiasis Price (USD/K Units) by Application (2020-2031)
Figure 63. Drugs for Schistosomiasis Value Chain
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
